Pharmaceutical

Cognizant Collaborates with Medidata to Provide Specialized Support for Life Sciences Clients

The organizations plan to support clients through expanded partnership and offer broader access to Medidata's AI-powered technologies to accelerate clinical…

11 months ago

Kinectrics and Isotopia Enter Agreement for Supply of Gadolinium-160 (Gd-160) to Support Production of Terbium-161 (Tb-161) for Advanced Radiotherapeutics

TORONTO, Jan. 30, 2025 /PRNewswire/ -- Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia…

11 months ago

Co-Diagnostics, Inc. to Exhibit at BioUtah’s 2025 Life Sciences Day on the Hill

SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company…

11 months ago

Orchard Software Named Top LIS Vendor by 2025 Black Book Market Research for Seventh Consecutive Year

CARMEL, Ind., Jan. 30, 2025 /PRNewswire/ -- For the seventh consecutive year, the Black Book Market Research User Survey has…

11 months ago

Atreo and N-SIDE Announce Preferred Partnership to Optimize Clinical Trial Operations

Atreo's Partnership with N-SIDE Integrates Modern RTSM Solutions with Advanced Forecasting Capabilities SAN FRANCISCO, Jan. 30, 2025 /PRNewswire/ -- Atreo,…

11 months ago

Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation

Rebranding Signals Strategic Shift Beyond Biopharmaceuticals, Highlights Commitment to Technology, Artificial Intelligence and Shareholder Value WEXFORD, Pa., Jan. 30, 2025…

11 months ago

Cognizant and Gilead Expand Partnership to Drive Greater Value Through Advanced Technology Applications

Cognizant will provide AI-driven solutions to enhance customer service, employee engagement, and business value TEANECK, N.J., Jan. 30, 2025 /PRNewswire/…

11 months ago

Red Light Holland, in Partnership with FDA-Compliant and DEA-Registered Irvine Labs, Updates R&D Plan Focused On Commercialization

Toronto, Ontario--(Newsfile Corp. - January 30, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light…

11 months ago

Orion and Invenra announce discovery service and commercial license agreement to develop innovative bispecific antibody cancer therapeutics

ORION CORPORATION PRESS RELEASE 30 JANUARY 2025 at 16.00 EET                   Orion and Invenra announce discovery service and commercial license…

11 months ago

Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences

SAN FRANCISCO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel…

11 months ago